HPV 28 Genotyping Kit - Taizhou Cowingene Biotech Co., Ltd.

The Cowingene HPV 28 Genotyping Detection Kit (Liquid) represents a significant advancement in the early detection and management of human papillomavirus (HPV) infections. Designed for clinical laboratories, this kit offers a comprehensive solution for identifying 28 high-risk HPV subtypes, including 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73, 81, 82, 83, and others. Developed by Taizhou Cowingene Biotech Co., Ltd., a leader in molecular diagnostics, this product combines cutting-edge PCR technology with user-friendly design to ensure precision and reliability in HPV screening.

Image: Advanced PCR technology enables accurate HPV genotyping.

Core Features and Advantages

The Cowingene HPV 28 Genotyping Kit is engineered to deliver exceptional performance in clinical settings. Key features include:

• Comprehensive Coverage: Detects 28 high-risk HPV subtypes, providing a detailed risk assessment for cervical cancer and other HPV-related conditions.
• High Sensitivity and Specificity: Utilizes advanced polymerase chain reaction (PCR) technology to ensure accurate identification of even low-abundance viral DNA.
• Flexible Sample Types: Validated for use with cervical swabs, urine, and self-collected vaginal specimens, making it suitable for diverse patient populations.
• Streamlined Workflow: Designed for rapid processing, reducing the time required for sample preparation and analysis compared to traditional methods.
• Compliance with Industry Standards: Meets regulatory requirements for diagnostic accuracy and safety, ensuring reliable results for healthcare providers and patients.

Image: PCR-based detection ensures precise HPV genotyping results.

Technical Specifications

Parameter	Details
Test Type	28-Genotype HPV Detection
Sample Types	Cervical swab, Urine, Self-collected vaginal
Target Subtypes	16, 18, 26, 31, 33, 35, 39, 40, 42, 43, 44, 45, 51, 52, 53, 55, 56, 58, 59, 61, 66, 68, 73, 81, 82, 83
Technology	PCR-based Real-Time Detection
Kit Components	8 reaction tubes, reagents, controls, and detailed protocols
Storage Conditions	-20°C for long-term storage; 4°C for short-term use
Shelf Life	12 months from the date of manufacture

Image: The kit’s components are designed for ease of use and accuracy.

Application Scenarios

The Cowingene HPV 28 Genotyping Kit is ideal for a wide range of clinical and research applications, including:

• Cervical Cancer Screening: Identifies high-risk HPV subtypes to enable early intervention and reduce the risk of cervical cancer progression.
• Public Health Programs: Supports large-scale HPV testing initiatives, particularly in regions with limited access to advanced diagnostic tools.
• Research Studies: Provides reliable data for epidemiological studies on HPV prevalence and genotype distribution.
• Diagnostic Laboratories: Offers a cost-effective solution for labs seeking to enhance their molecular testing capabilities.
• Telemedicine Integration: Facilitates remote testing through self-collected vaginal specimens, expanding access to underserved populations.

Company Background: Taizhou Cowingene Biotech Co., Ltd.

Taizhou Cowingene Biotech Co., Ltd. is a leading innovator in molecular diagnostics, specializing in the development of advanced solutions for infectious disease detection. With a focus on precision and reliability, the company has established itself as a trusted partner for healthcare providers and researchers worldwide. Cowingene’s commitment to scientific excellence is reflected in its state-of-the-art facilities and rigorous quality control processes.

As a company deeply invested in improving public health, Cowingene continues to expand its portfolio of diagnostic products, including PCR-based assays for HPV, HIV, and other pathogens. The HPV 28 Genotyping Kit exemplifies the company’s dedication to advancing women’s health through cutting-edge technology.

Scientific Validation and Regulatory Compliance

The Cowingene HPV 28 Genotyping Kit has undergone extensive validation to ensure its accuracy and reliability. According to the National Institute of Standards and Technology (NIST), rigorous testing protocols are essential for molecular diagnostic assays to meet clinical standards. NIST’s role in establishing measurement standards for biological samples underscores the importance of tools like the Cowingene kit in ensuring consistent and reproducible results.

As noted in a NIST publication, "Standardized methodologies for HPV detection are critical for reducing diagnostic variability and improving patient outcomes." The Cowingene kit aligns with these principles, offering a solution that adheres to international guidelines for molecular diagnostics.

Conclusion

The Cowingene HPV 28 Genotyping Detection Kit (Liquid) is a transformative tool in the fight against HPV-related diseases. By combining advanced PCR technology with a user-friendly design, this product empowers healthcare professionals to deliver accurate, timely, and actionable results. Whether used in clinical settings, research, or public health initiatives, the kit represents a significant step forward in the early detection and management of HPV infections.

For more information about the Cowingene HPV 28 Genotyping Kit or to explore other diagnostic solutions from Taizhou Cowingene Biotech Co., Ltd., visit their official website.

References

National Institute of Standards and Technology (NIST). (n.d.). Standards for Molecular Diagnostics. Retrieved from https://www.nist.gov.

NIST. (2025). Advancing HPV Detection through Precision Measurement. Retrieved from https://www.nist.gov.